Wells Fargo & Company Valneva Se Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Valneva Se stock. As of the latest transaction made, Wells Fargo & Company holds 243,218 shares of VALN stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
243,218
Previous 246,766
1.44%
Holding current value
$1.52 Million
Previous $1.08 Million
51.3%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VALN
# of Institutions
15Shares Held
663KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.21 Million0.18% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il27.2KShares$169,5740.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$155,8870.1% of portfolio
-
Morgan Stanley New York, NY5.2KShares$32,4200.0% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD4KShares$24,9200.01% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $431M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...